New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
07:06 EDTTBIOTransgenomic Inc announces issuance of U.S. patent for ICE COLD-PCR
Transgenomic announced that the U.S. Patent and Trademark Office has issued a new patent related to its licensed ICE COLD-PCR technology. The patent, titled “Full cold-PCR enrichment with reference blocking sequence”, was assigned U.S. Patent No. 8,623,603 and is set to expire in 2031. The new U.S. patent extends the scope and longevity of the COLD-PCR intellectual property portfolio. The '603 patent covers ICE COLD-PCR methods for enriching low abundance alleles in nucleic acid samples. It is directed in particular to the use of an excess amount of reference blocking sequence in an amplification reaction mixture in order to improve the enrichment efficiency, and reduce cycle time, of full COLD-PCR.
News For TBIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
09:11 EDTTBIOTransgenomic 3.574M share Secondary priced at $1.95
Craig-Hallum acted as sole book running manager for the offering.
06:33 EDTTBIOTransgenomic raises $6.2M through an equity offering
Subscribe for More Information
February 26, 2015
17:10 EDTTBIOTransgenomic Inc files automatic common stock shelf
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use